When did entresto go generic?

As of now, Entresto (sacubitril/valsartan) has not gone generic in the United States. There are no FDA-approved generic versions available.

Reason: Entresto is protected by multiple patents and exclusivities, and generic entry is not expected until those protections expire, which is typically in the early 2030s (exact timing can depend on patent litigation outcomes, extensions, and regulatory decisions).

If you want the latest status, you can check:
- FDA Orange Book entry for sacubitril/valsartan (to see current patent and exclusivity status)
- News or updates from regulatory agencies or major pharmaceutical filings for any changes in status

If you’re in a country outside the U.S., generic availability may differ, so local regulatory information could show a different timeline. If you’d like, I can look up the most current status for a specific country.